GlassScriptPhysician profile
Lily L Moore
NPI 1609943703
$3,592.19
in general payments reported to CMS, 2019-2025
42 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $584 · 2021: $306 · 2022: $600 · 2023: $1,174 · 2024: $327 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,707.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $566.41 | 2019-2025 | Stravix, Grafix Pl, Grafix Xc |
| Musculoskeletal Transplant Foundation INC. | $441.34 | 2020-2022 | |
| Epsfl, LLC | $411.36 | 2023 | |
| Averitas Pharma INC. | $281.17 | 2023-2025 | Qutenza |
| Acera Surgical, INC. | $238.61 | 2022-2023 | Restrata Wound Matrix |
| Nevro Corp. | $134.06 | 2021-2024 | Senza |
| Convatec INC. | $121.27 | 2020-2024 | |
| Amniox Medical, INC. | $99.99 | 2019 | |
| Next Science LLC | $97.37 | 2022-2023 | Surgx, Xperience, Blastx |
| Depuy Synthes Sales INC. | $77.62 | 2019-2021 | |
| Organogenesis INC. | $73.66 | 2023-2024 | Puraply |
| Bioventus LLC | $69.02 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $67.80 | 2019-2024 | Variax, Actishield Cf, Spy-Phi System |
| Treace Medical Concepts, INC. | $64.06 | 2022 | |
| Kerecis Limited | $58.55 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
Show all 41 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$87,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.